Skip to main content

Stonnington Group, LLC

SEC CIK
0001325261
Latest filing
Apr 14, 2023

PCRX holding history

Pacira BioSciences, Inc. in every 13F filed by Stonnington Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCRX overviewAll 13F holders of PCRXFull Q1 2023 holdings

Shares (Q1 2023)
12,019
Value
$507.1K
% of portfolio
0.1%
Quarters held
9
Since Q1 2021
Holdings of PCRX by Stonnington Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 202312,019$507.1K0.1%−2,000−14.3%ReducedHolders
Q4 202214,019$523.9K0.1%−15,500−52.5%ReducedHolders
Q3 202229,519$1.57M0.4%+6,422+27.8%AddedHolders
Q2 202223,097$1.34M0.4%−23,500−50.4%ReducedHolders
Q1 202246,597$3.41M0.8%+1,050+2.3%AddedHolders
Q4 202145,547$2.83M0.6%+24,100+112.4%AddedHolders
Q3 202121,447$1.03M0.2%−4,100−16.0%ReducedHolders
Q2 202125,547$1.44M0.3%+500+2.0%AddedHolders
Q1 202125,047$1.55M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.